Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
NewMarket
NEU
$8.22B
| $16.4M | 0.02% |
23,700
+20,200
| +577% | +$12.5M |
2018 Q4
26 quarters
|
|
802
Banco Santander Chile
BSAC
$15.2B
| $16.3M | 0.02% |
647,727
-212,800
| -25% | -$5.13M |
2015 Q3
39 quarters
|
|
803
Federated Hermes
FHI
$4.22B
| $16.3M | 0.02% |
367,700
+283,900
| +339% | +$11.7M |
2023 Q3
7 quarters
|
|
804
Vanda Pharmaceuticals
VNDA
$276M
| $16.3M | 0.02% |
3,447,460
-118,965
| -3% | -$520K |
2015 Q4
38 quarters
|
|
805
Quanex
NX
$838M
| $16.3M | 0.02% |
860,807
-116,300
| -12% | -$2.06M |
2013 Q4
46 quarters
|
|
806
Sonoco
SON
$4.74B
| $16.3M | 0.02% |
373,300
+14,400
| +4% | +$644K |
2024 Q4
2 quarters
|
|
807
Invesco S&P 500 Equal Weight ETF
RSP
$97.5B
| $16.2M | 0.02% |
+89,400
| New | +$15.4M |
2025 Q2
0 quarters
|
|
808
IQVIA
IQV
$42.8B
| $16.2M | 0.02% |
103,047
-154,800
| -60% | -$23.3M |
2024 Q2
4 quarters
|
|
809
Graham Corp
GHM
$967M
| $16.1M | 0.02% |
325,068
-2,600
| -0.8% | -$96.4K |
2013 Q2
48 quarters
|
|
810
Progyny
PGNY
$2.14B
| $16M | 0.02% |
+727,800
| New | +$16M |
2025 Q2
0 quarters
|
|
811
Atmus Filtration Technologies
ATMU
$3.49B
| $16M | 0.02% |
438,900
+23,800
| +6% | +$849K |
2024 Q2
4 quarters
|
|
812
Merit Medical Systems
MMSI
$5.21B
| $16M | 0.02% |
170,912
+4,300
| +3% | +$407K |
2024 Q1
5 quarters
|
|
813
LSI Industries
LYTS
$769M
| $15.9M | 0.02% |
935,692
+10,500
| +1% | +$169K |
2015 Q2
40 quarters
|
|
814
Symbotic
SYM
$5.54B
| $15.9M | 0.02% |
+409,500
| New | +$10.7M |
2025 Q2
0 quarters
|
|
815
Applied Digital
APLD
$7.16B
| $15.9M | 0.02% |
+1,578,000
| New | +$11.6M |
2025 Q2
0 quarters
|
|
816
iShares Broad USD High Yield Corporate Bond ETF
USHY
$25.9B
| $15.8M | 0.02% |
+421,457
| New | +$15.5M |
2025 Q2
0 quarters
|
|
817
Church & Dwight Co
CHD
$23.3B
| $15.8M | 0.02% |
164,110
+100,900
| +160% | +$9.95M |
2019 Q1
25 quarters
|
|
818
ScottsMiracle-Gro
SMG
$2.9B
| $15.7M | 0.02% |
+238,600
| New | +$13.8M |
2025 Q2
0 quarters
|
|
819
Louisiana-Pacific
LPX
$4.59B
| $15.7M | 0.02% |
182,600
+60,700
| +50% | +$5.39M |
2024 Q1
5 quarters
|
|
820
Brookfield Asset Management
BAM
$73.3B
| $15.7M | 0.02% |
284,000
-93,200
| -25% | -$5M |
2024 Q1
5 quarters
|
|
821
Waterstone Financial
WSBF
$350M
| $15.7M | 0.02% |
1,134,936
-21,100
| -2% | -$270K |
2013 Q2
48 quarters
|
|
822
Wyndham Hotels & Resorts
WH
$5.5B
| $15.6M | 0.02% |
192,500
+103,500
| +116% | +$8.66M |
2024 Q1
5 quarters
|
|
823
Phibro Animal Health
PAHC
$1.56B
| $15.6M | 0.02% |
610,800
-94,500
| -13% | -$2.06M |
2016 Q4
34 quarters
|
|
824
Robert Half
RHI
$3.47B
| $15.6M | 0.02% |
+379,000
| New | +$17.3M |
2025 Q2
0 quarters
|
|
825
iShares Preferred and Income Securities ETF
PFF
$12.2B
| $15.5M | 0.02% |
506,800
+463,200
| +1,062% | +$13.9M |
2025 Q1
1 quarter
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.